Arch Dis Child Fetal Neonatal Ed. 2004 Jan; 89(1): F5-F8.
Mohan PV, Tarnow-Mordi W, Stenson B, Brocklehurst P, Haque K, Cavendish V, Cust A.
Department of Paediatrics, Baylor College of Medicine, Houston, TX 77025, USA. Department of Neonatology, Westmead Hospital, and Children’s Hospital at Westmead, Sydney, NSW 2145, Australia. The Royal infirmary of Edinburgh at Little France, Edinburgh, EH16 4SU, Scotland, UK. National Perinatal Epidemiology Unit, Institute of Health Services, Oxford, OX3 7LF, UK. Department of Child Health, Queen Mary’s Hospital for Children, Carshalton, Surrey SM5 1AA, UK. Department of Clinical Sciences at North Bristol (Orthopaedic Surgery), University of Bristol, Bristol BS10 5NB, UK. NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW 2006, Australia.
Recent evidence suggests that inflammatory cytokines may play an important role in cerebral and pulmonary injury, especially in preterm infants. Immunomodulatory agents may help to limit such injury by reducing inflammation. Immunoglobulin has multiple anti-inflammatory properties and can modulate the inflammatory cytokine response. New evidence is required to test the hypotheses that prophylaxis or treatment with intravenous immunoglobulin may limit such inflammatory damage.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!